26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Karuna R et al. Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography-mass spectrometry for the quantification of 27-hydroxycholesterol in plasma. 2009 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:19121981
Escher G et al. Role of CYP27A1 in progesterone metabolism in vitro and in vivo. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19671838
Li T and Chiang JY Regulation of bile acid and cholesterol metabolism by PPARs. 2009 PPAR Res pmid:19636418
Mateos L et al. Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. 2009 Brain Pathol. pmid:18503570
Wang Y et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. 2009 Mol Biosyst pmid:19381367
Zhou C et al. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. 2009 Nucl Recept Signal pmid:19240808
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Mathieu JM et al. Medical bioremediation of age-related diseases. 2009 Microb. Cell Fact. pmid:19358742
Lange Y et al. Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. 2009 J. Lipid Res. pmid:19401598
van den Kommer TN et al. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? 2009 Neurobiol. Aging pmid:17888546
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Kim WS et al. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. 2009 J. Alzheimers Dis. pmid:19158428
Hirayama T et al. Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level. 2009 Hepatol. Res. pmid:19208035
Tang W et al. Glucocorticoid receptor-mediated upregulation of human CYP27A1, a potential anti-atherogenic enzyme. 2008 Nov-Dec Biochim. Biophys. Acta pmid:18817892
Patel MB et al. Liver x receptor: a novel therapeutic target. 2008 Mar-Apr Indian J Pharm Sci pmid:20046702
Mosig S et al. Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism. 2008 BMC Med Genomics pmid:19040724
de Vogel-van den Bosch HM et al. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18356535
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Ghribi O Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. 2008 J. Alzheimers Dis. pmid:19096164
Cheng D et al. Regulation of alpha-synuclein expression by liver X receptor ligands in vitro. 2008 Neuroreport pmid:18841091
Lange Y et al. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. 2008 J. Biol. Chem. pmid:18024962
Zhang JR et al. Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. 2008 J. Clin. Invest. pmid:18483620
DuSell CD et al. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. 2008 Mol. Endocrinol. pmid:17872378
Crosignani A et al. Plasma oxysterols in normal and cholestatic children as indicators of the two pathways of bile acid synthesis. 2008 Clin. Chim. Acta pmid:18538136
Lee CY et al. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. 2008 Free Radic. Biol. Med. pmid:18226605
Rantham Prabhakara JP et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. 2008 J. Neurochem. pmid:19014385
Yoshida T et al. Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry. 2008 Anal Chem Insights pmid:19609389
Griffiths WJ et al. Discovering oxysterols in plasma: a window on the metabolome. 2008 J. Proteome Res. pmid:18605750
Sharma S et al. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. 2008 Neurobiol. Dis. pmid:18775495
DuSell CD and McDonnell DP 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. 2008 Trends Pharmacol. Sci. pmid:18722677
DiBlasio-Smith EA et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. 2008 J Transl Med pmid:18925943
Szatmari I and Nagy L Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. 2008 EMBO J. pmid:18716631
Duron E and Hanon O Vascular risk factors, cognitive decline, and dementia. 2008 Vasc Health Risk Manag pmid:18561512
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Hojo K et al. Determination of total cholesterol in serum by high-performance liquid chromatography with electrochemical detection. 2007 J Chromatogr A pmid:17723233
Meaney S et al. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. 2007 J. Lipid Res. pmid:17251592
Gueguen Y et al. Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase. 2007 Basic Clin. Pharmacol. Toxicol. pmid:17516993
Li T et al. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. 2007 J. Lipid Res. pmid:17088262
Teunissen CE et al. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. 2007 J. Neurosci. Res. pmid:17410599
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Jiang X et al. Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. 2007 Rapid Commun. Mass Spectrom. pmid:17154356
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Luomala M et al. Osteopontin levels are associated with cholesterol synthesis markers in mildly hypercholesterolaemic patients. 2007 Acta Cardiol pmid:17536607
Crosignani A et al. Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. 2007 Clin. Chim. Acta pmid:17482152
Li X et al. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes. 2007 J. Lipid Res. pmid:17890683
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
van den Bosch HM et al. Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting. 2007 BMC Genomics pmid:17683626
Larsson DA et al. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. 2006 Free Radic. Biol. Med. pmid:16934673
Holzapfel J et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease. 2006 Neurosci. Lett. pmid:16979821